
Full INTerpath-001 results show the individualized mRNA therapy plus pembrolizumab reduced recurrence risk in resected stage IIB-IV melanoma.
Supplements and Featured Publications
almost 28 years ago
An Overview of Viral Hepatitisalmost 28 years ago
Viral Hepatitis: Impact, Treatment, and Costsalmost 28 years ago
New Epidemiologic Data on Hepatitis B and Calmost 28 years ago
Appropriate Screening and Early Diagnosis of Hepatitis B and Calmost 28 years ago
Clinical Utility of HCV RNA Monitoring for Patients with Chronic Hepatitis Calmost 28 years ago
State-of-the-Art Interferon Therapy for Chronic Viral Hepatitisalmost 28 years ago
Cost Effectiveness of Treating Chronic Hepatitis B and Calmost 28 years ago
Chronic Hepatitis C: An Overviewalmost 28 years ago
Chronic Hepatitis C: Impact, Diagnosis, and Treatmentalmost 28 years ago
Selected Abstracts





